Demethylation by 5-azacytidine results in the expression of hepatitis B virus surface antigen in transgenic mice

Jpn J Cancer Res. 1989 Apr;80(4):295-8. doi: 10.1111/j.1349-7006.1989.tb02308.x.

Abstract

In 14p3HB transgenic mice, which carry three tandem copies of hepatitis B virus (HBV) DNA, the HBV DNA was significantly methylated and no viral proteins were produced. To analyze the causal relationship between hypermethylation and gene inactivity, 5-azacytidine was injected into the mice to demethylate HBV DNA. When postnatal 14p3HB mice were treated with the drug, hepatitis virus surface antigen was produced in these mice by 3 weeks of age, and the integrated HBV DNA of the liver was less heavily methylated. Our results suggest that injection of 5-azacytidine can be used to efficiently activate a silent transgene such as HBV DNA in transgenic mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Azacitidine / pharmacology*
  • Blotting, Northern
  • Gene Expression Regulation / drug effects*
  • Hepatitis B Surface Antigens / genetics*
  • Hepatitis B e Antigens / genetics
  • Methylation
  • Mice
  • Mice, Transgenic
  • RNA, Messenger / genetics

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • RNA, Messenger
  • Azacitidine